Your browser doesn't support javascript.
loading
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA.
Dahlqvist, Johanna; Ekman, Diana; Sennblad, Bengt; Kozyrev, Sergey V; Nordin, Jessika; Karlsson, Åsa; Meadows, Jennifer R S; Hellbacher, Erik; Rantapää-Dahlqvist, Solbritt; Berglin, Ewa; Stegmayr, Bernd; Baslund, Bo; Palm, Øyvind; Haukeland, Hilde; Gunnarsson, Iva; Bruchfeld, Annette; Segelmark, Mårten; Ohlsson, Sophie; Mohammad, Aladdin J; Svärd, Anna; Pullerits, Rille; Herlitz, Hans; Söderbergh, Annika; Rosengren Pielberg, Gerli; Hultin Rosenberg, Lina; Bianchi, Matteo; Murén, Eva; Omdal, Roald; Jonsson, Roland; Eloranta, Maija-Leena; Rönnblom, Lars; Söderkvist, Peter; Knight, Ann; Eriksson, Per; Lindblad-Toh, Kerstin.
Affiliation
  • Dahlqvist J; Department of Medical Sciences.
  • Ekman D; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Sennblad B; Broad Institute of MIT and Harvard University, Cambridge, MA, USA.
  • Kozyrev SV; Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Stockholm.
  • Nordin J; Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala.
  • Karlsson Å; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Meadows JRS; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Hellbacher E; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Rantapää-Dahlqvist S; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Berglin E; Department of Medical Sciences.
  • Stegmayr B; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Baslund B; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Palm Ø; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Haukeland H; Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Gunnarsson I; Department of Rheumatology, Oslo University Hospital.
  • Bruchfeld A; Department of Rheumatology, Martina Hansens Hospital, Oslo, Norway.
  • Segelmark M; Department of Medicine, Division of Rheumatology, Karolinska Institutet, Stockholm.
  • Ohlsson S; Unit of Rheumatology, Karolinska University Hospital, Stockholm.
  • Mohammad AJ; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping.
  • Svärd A; Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm.
  • Pullerits R; Department of Clinical Sciences, Division of Nephrology, Lund University and Skåne University Hospital.
  • Herlitz H; Department of Clinical Sciences, Division of Nephrology, Lund University and Skåne University Hospital.
  • Söderbergh A; Department of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Rosengren Pielberg G; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Hultin Rosenberg L; Center for Clinical Research Dalarna, Uppsala University, Uppsala.
  • Bianchi M; Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg.
  • Murén E; Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital.
  • Omdal R; Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Jonsson R; Department of Rheumatology, Örebro University Hospital, Örebro, Sweden.
  • Eloranta ML; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Rönnblom L; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Söderkvist P; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Knight A; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Eriksson P; Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger.
  • Lindblad-Toh K; Department of Clinical Science.
Rheumatology (Oxford) ; 61(8): 3461-3470, 2022 08 03.
Article in En | MEDLINE | ID: mdl-34888651
OBJECTIVE: To identify and characterize genetic loci associated with the risk of developing ANCA-associated vasculitides (AAV). METHODS: Genetic association analyses were performed after Illumina sequencing of 1853 genes and subsequent replication with genotyping of selected single nucleotide polymorphisms in a total cohort of 1110 Scandinavian cases with granulomatosis with polyangiitis or microscopic polyangiitis, and 1589 controls. A novel AAV-associated single nucleotide polymorphism was analysed for allele-specific effects on gene expression using luciferase reporter assay. RESULTS: PR3-ANCA+ AAV was significantly associated with two independent loci in the HLA-DPB1/HLA-DPA1 region [rs1042335, P = 6.3 × 10-61, odds ratio (OR) 0.10; rs9277341, P = 1.5 × 10-44, OR 0.22] and with rs28929474 in the SERPINA1 gene (P = 2.7 × 10-10, OR 2.9). MPO-ANCA+ AAV was significantly associated with the HLA-DQB1/HLA-DQA2 locus (rs9274619, P = 5.4 × 10-25, OR 3.7) and with a rare variant in the BACH2 gene (rs78275221, P = 7.9 × 10-7, OR 3.0), the latter a novel susceptibility locus for MPO-ANCA+ granulomatosis with polyangiitis/microscopic polyangiitis. The rs78275221-A risk allele reduced luciferase gene expression in endothelial cells, specifically, as compared with the non-risk allele. CONCLUSION: We identified a novel susceptibility locus for MPO-ANCA+ AAV and propose that the associated variant is of mechanistic importance, exerting a regulatory function on gene expression in specific cell types.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Granulomatosis with Polyangiitis / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Microscopic Polyangiitis Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Granulomatosis with Polyangiitis / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Microscopic Polyangiitis Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article